Learn more

BIONORICA AG

Overview
  • Total Patents
    112
  • GoodIP Patent Rank
    233,544
About

BIONORICA AG has a total of 112 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and chemical engineering are NOVACEA INC, ATHPHARMA LTD and TIANJIN TASLY PHARMACEUTICAL.

Patent filings per year

Chart showing BIONORICA AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Popp Michael A 39
#2 Wuttke Wolfgang 34
#3 Christoffel Volker 33
#4 Jarry Hubertus 31
#5 Spengler Barbara 30
#6 Popp Michael 25
#7 Joseph Heinz-Walter 13
#8 Bonn Guenther 9
#9 Stierna Pontus 4
#10 Huck Christian W 4

Latest patents

Publication Filing date Title
WO2010049542A2 Plant extract hydrolysates and antibacterial product containing the same
DE102009011152A1 New plant extract hydrolysates of e.g. Equiseti herba and/or Juglandis folium, obtained by hydrolytic treatment with mineral acid, useful e.g. as antibacterial agent for prophylaxis and treatment of infections e.g. rhinitis and sinusitis
DE102008054127A1 Hydrolysate of an extract of plant material comprising e.g. Equiseti herba (horsetail), Juglandis folium (walnut leaves) and Millefolii herba, obtained by hydrolytic treatment with a mineral acid, useful for treating bacterial infections
DE102008018916A1 Method and device for cleaning the ear canal
DE102007052223A1 Hydrolysates of plant extracts and antibacterial agent containing them
DE102007044916A1 Cosmetic or dermatological composition for topical use
DE102007027569B3 A method for qualitatively classifying surfactant-containing compositions
US2008177481A1 Method for classifying scientific materials such as silicate materials, polymer materials and/or nanomaterials
DE102005053926B3 Use of antibacterial agent from mixture of plant drugs, comprises Rumex acetosa L.-family, Rumicis herba, Verbena officinalis, Sambucus nigra, Primula veris and Gentiana lutea, e.g. to treat infection on topical skin and mucous membrane
DE102005028937A1 Process for the preparation of dronabinol
US2005037100A1 Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic
DE102004014726A1 Psychopharmacologically effective plant-based medicine
DE10341579A1 Use of extracts of Gentiana lutea as an antimicrobial agent
DE10206390A1 Use of phytoestrogen-containing extracts that selectively modulate the estrogen receptor beta
DE10146159A1 Use of extracts from Cimicifuga species as an organ-selective drug for the treatment of sex hormone-dependent diseases of the urogenital tract
DE10127897A1 Coated tablet with dry plant extracts
DE10125740A1 Use of plants of the genus Hypericum to facilitate the synchronization of a circadian rhythm
DE10124917A1 Method for classifying wine and coffee
DE10123503A1 Use of Belamcanda chinensis extract, or its active ingredient, for treating sex hormone-dependent urogenital disorders and prostatic hyperplasia
DE10112167A1 Process for the gentle extraction of dry extracts